Merck breaks ground on new $1bn biologics center of excellence in Delaware

Merck, known as MSD outside of the United States and Canada, has started construction on a $1bn, 470,000-square-foot state-of-the-art biologics center of excellence in Wilmington, Delaware. A cornerstone of Merck’s continued commitment to investing in American innovation and infrastructure, Merck Wilmington Biotech will comprise laboratory, manufacturing and warehouse capabilities to enable the launch and commercial…